The Montreal Clinical Research Institute (IRCM), which brings together researchers in the field of life sciences, sees Quebec’s financial support renewed to support its operations and its research activities at least just until 2024.
A contribution of more than $ 31.1 million was announced Monday by the Ministers of Economy and Innovation, Pierre Fitzgibbon, and Health and Social Services, Christian Dubé.
These totals will allow our researchers, our clinicians, and all their teams, to continue their work in all fields, even in debilitating diseases such as cancer, metabolic disease, rare diseases. , among others, or biomedical technology. art, such as RNA, but also for clinical research practices said Dr. Jean-François Côté, Scientific Director and Acting President ofIRCM .
He mentioned the various projects being carried out and put together thanks to new help from Quebec. Among other things, he cited research into RNA, type 1 diabetes, therapeutic monoclonal antibodies that act on cancer or infections such as COVID-19, as well as the development of artificial intelligence tools.
The funding allocated is in line with the goals of Quebec’s strategies for the life sciences, and research and investment in innovation with the goal of transferring laboratory findings to businesses and commercialization, Mr. Fitzgibbon indicated at the conference.
We want to connect all players to the innovation cycle and accelerate the transition from idea to market. Simply put, we want to link research and investment to increase business productivity and create more wealth for Quebec.he said.
A necessity, Dubé said
Mr. Dubé argued that research clinics are a must to enable change in the healthcare network, featuring pioneering the work ofIRCM in the long COVID for over a year.
He said he wanted to define common thread priority research needed for the health network in the summer, specifically in put the money in the right place.
Is it at the level of rare diseases, are all our processes? It is able to tell researchers: “here’s more specifically where we want to do research because that’s where we need health”. This identity is important explained Mr. Dubé.
L ‘IRCMpeople get sick and clog the frontline systemargument by Dr. Side.
develop more than 165 projects per year. These clinics help more than 7,000 patients and have a volume of more than 21,000 visits annually, preventingSource: Radio-Canada